baber/WOPTO huggingface dataset:
Patent AU-2010221462-A1 (AU)
Title: Collateral management system and method
Inventor: KELLY MATHIESON
IPC: G06Q40/00
Filed: 2010-03-02
Abstract: A collateral management system and method for managing collateral of multiple participants including borrowers and lenders. A global long box available to each borrower, configured for storing all types of available assets possessed by each borrower. An eligibility database storing eligibility and concentration limits, the concentration limits defined by lender rules controlling the acceptability of the available assets as collateral, the value of the assets, and overall acceptable composition of assets. An interactive participant interface for accepting collateral use preferences from the borrowers, the collateral use preferences including ranking components for lenders and assets, and allocation run type selection components for facilitating collateral allocation. An allocation engine for selecting a collateral allocation sequence based on the collateral use preferences of the borrowers, and in compliance with the stored eligibility and concentration limits in the eligibility database.
Patent AU-2010224485-A1 (AU)
Title: Use of pharmaceutical compositions containing mesembrenone
Inventor: Alan harvey
IPC: A61P1/00
Filed: 2010-03-16
Abstract: The use of mesembrenone and medicaments and dietary supplements containing mesembrenone. The applicant has surprisingly found that mesembrenone exhibits potent PDE-4 inhibition properties and, in addition to being useful in treating conditions that respond to treatment with a PDE-4 inhibitor, has dual activity on account of its serotonin-uptake inhibition properties. Mesembrenone is extracted and isolated, for example as a pure compound, from plant material of the plant family Mesembryanthemaceae. Preferably a plant or plants from the genus Sceletium, more preferably, Sceletium tortuosum(L) N.E.Br is used.
Patent AU-2010231439-A1 (AU)
Title: Method for manufacturing 1,5-benzodiazepine derivative
Inventor: MASARU TERAUCHI
IPC: A61P1/04
Filed: 2010-03-29
Abstract: Disclosed is a commercially advantageous method for manufacturing a 1,5-benzodiazepine compound. A compound (5) is obtained from a reaction formula and used as an intermediate.
Patent AU-2010262756-A1 (AU)
Title: Determining haemodynamic performance
Inventor: STEPHEN WOODFORD
IPC: G16B45/00
Filed: 2010-06-17
Abstract: A method for determining haemodynamic performance in a human or animal subject comprises receiving at a processor data representing haemodynamic variables measured from the subject over time. The haemodynamic variables comprise at least two of Systemic Perfusion Pressure (SPP), Systemic Vascular Resistance (SVR), Cardiac Output (CO), Heart Rate (HR) and Stroke Volume (SV). The data are processed to produce a display signal for causing a display device to present a visual mapping relating the haemodynamic variables according to the relationship and the visual mapping is displayed on a display device. The visual mapping may be corrected Heart Rate (HR) or include a second mapping which facilitates an adjustment to take account of HR.
Patent AU-2010278930-A1 (AU)
Title: Huber needle with safety tube
Inventor: SCHWEIKERT TIMOTHY M
IPC: A61M5/32
Filed: 2010-07-29
Abstract: A Huber needle assembly includes a needle, a safety tube substantially around at least a portion of the needle, and a skin plate at one end of the safety tube. The safety tube is adapted to irretractably extend over the needle.
Patent AU-2010281291-A1 (AU)
Title: Polymer ceramic composite
Inventor: FORREST MARK
IPC: B32B27/18
Filed: 2010-08-04
Abstract: There is provided a polymer ceramic composite which includes one or more particulate ceramics and a mixture of polymers. There is further provided methods of manufacture and application of the polymer ceramic composition. The composition finds use as a mouldable armour strike face, particularly in personal protective equipment and in vehicle or aircraft armour.
Patent AU-2010288477-A1 (AU)
Title: (thio)morpholine derivatives as S1P modulators
Inventor: IWEMA BAKKER WOUTER I
IPC: C07D417/12
Filed: 2010-08-27
Abstract: The present invention relates to (thio)morpholine derivatives of the formula (I), wherein R1 is selected from cyano, (2-4C)alkynyl, (1-4C)alkyl, (3-6C)cycloalkyl, (4-6C)cycloalkenyl, (6-8C)bicycloalkyl, (8-10C)bicyclic group, each optionally substituted with (1-4C)alkyl, phenyl, biphenyl, naphthyl, each optionally substituted with one or more substituents independently selected from halogen, (1-4C)alkyloptionally substituted with one or more fluoro atoms, (2-4C)alkynyl, (1-4C)alkoxy optionally substituted with one or more fluoro atoms,amino, di(1-4C)alkylamino, -SO-(1-4C)alkyl, -CO-(1-4C)alkyl, -CO-O-(1-4C)alkyl, -NH-CO-(1-4C)alkyl and (3-6C)cycloalkyl, phenyl substituted with phenoxy, benzyl, benzyloxy, phenylethyl or monocyclic heterocycle, each optionally substituted with (1-4C)alkyl, monocyclic heterocycle optionally substituted with halogen, (1-4C)alkyl or with phenyl optionally substituted with (1-4C)alkyl, and bicyclic heterocycle optionally substituted with (1-4C)alkyl; A is selected from -CO-O-, -O-CO-, -NH-CO-, -CO-NH, -C=C-, -CCH-O- and the linking group –Y-(CH)-X- wherein Y is attached to R1 and selected from a bond, -O-, -S-, -SO-, -SO-, -CH-O-, -CO-, -O-CO-, -CO-O-, -CO-NH-, -NH-CO-, -C=C-and -C≡C-; n is an integer from 1 to 10; and X is attached to the phenylene / pyridyl group and selected from a bond, -O-, -S-, -SO-, -SO -, -NH, -CO-, -C=C-and -C≡C-; ring structure B optionally contains one nitrogen atom; R2 is H, (1-4C)alkyl optionally substituted with one or more fluoro atoms, (1-4C)alkoxy optionally substituted with one or more fluoro atoms, or halogen; and R3 is (1-4C)alkylene-R5 wherein the alkylene group may be substituted with (CH) to form a cyclopropyl moiety or one or two halogen atoms, or R3 is is (3-6C)cycloalkylene-R5 or -CO-CH-R5, wherein R5 is -OH, -POH, -OPOH, -COOH, -COO(1-4C)alkyl or tetrazol-5-yl; R4 is H or (1-4C)alkyl; R6 is one or more substituents independently selected from H, (1-4C)alkyl or oxo; W is -O-, -S-, -SO- or -SO-; or a pharmaceutically acceptable salt, a solvate or hydrate thereof; with the proviso that the derivative of formula (I) is not 2-(4-ethylphenyl)-4-morpholinoethanol or 4-[4-(2-hydroxyethyl)-2-morpholinyl]benzeneacetonitrile or a pharmaceutically acceptable salt, a solvate or hydrate thereof. The compounds of the invention have affinity to S1P receptors and may be used in the treatment, alleviation or prevention of S1P receptor mediated diseases and conditions.
Patent AU-2010299579-A1 (AU)
Title: Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
Inventor: CHARRIER JEAN-DAMIEN
IPC: C07D475/00
Filed: 2010-09-24
Abstract: A method of preparing a compound represented by Structural Formula (I), or a pharmaceutically acceptable salt thereof, wherein the variables of Structural Formula (I) are as described in the specification and claims, comprises the steps of: a) reacting a compound represented by Structural Formula (A) with FTNRR under suitable conditions to form a compound represented by Structural Formula (B); and b) i) when R is -NO, and R is -OR: 1) cyclizing the compound represented by Structural Formula (B) under suitable cyclisation conditions to form a compound represented by Structural Formula (II); and 2) optionally reacting the compound represented by Structural Formula (II) with R-LG wherein LG is a suitable leaving group, to form the compound represented by Structural Formula (I), wherein R is R; or ii) when R is halogen, and R is -NHR: 1) cyclizing the compound represented by Structural Formula (B) under suitable cyclisation conditions to form the compound represented by Structural Formula (I); and 2) optionally, when R is - H, reacting the compound produced from step b), ii), 1) with R-LG, wherein LG is a suitable leaving group, to form the compound represented by Structural Formula (I) wherein R is R.
Patent AU-2010310515-A1 (AU)
Title: Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment
Inventor: LONGO VALTER D
IPC: A23L33/00
Filed: 2010-10-22
Abstract: The present invention relates to methods of protecting patients and sensitizing cancer cells in combination with chemotherapy and/or radiation therapy. More specifically, the invention provides nutritional methods and formulations that are capable of reducing cancer growth without causing chronic weight loss in patients, protecting normal cells, tissues and organs from chemotherapy and/radiation therapy, and sensitizing cancer cells against low, normal and high-dose chemotherapy. Some of the methods also impede cancer growth even without chemotherapy.
Patent AU-2010332767-A1 (AU)
Title: Tricyclic antibiotics
Inventor: GAUCHER BERANGERE
IPC: C07D491/04
Filed: 2010-12-17
Abstract: Compound of formula (I): wherein A1 represents -O-, -S- or -N-R3; A2 represents -CH-, -O-, -N-R4, -C(=O)- or -CH(O-R4)-; A3 represents C-Ccycloalkylene; saturated and unsaturated 4 to 8-membered heterocyclodiyl with 1, 2 or 3 heteroatoms selected from nitrogen, oxygen and sulphur, which group A3 is unsubstituted or substituted; A4 represents C-Calkylene, C-Calkenylene, >C=O or a group selected from - CHNH-, -CHO-, and -CHS- being linked to the adjacent NR5-group via the carbon atom; and G represents aryl or heteroaryl, which is unsubstituted or substituted and R1 and R2 independently of one another, represent hydrogen or a substituent selected from hydroxy, halogen, mercapto, cyano, nitro, C-Calkyl, C-Calkoxy, C-Calkylthio, C-Calkylcarbonyloxy, C-Calkylsulfonyloxy, C-Cheteroalkylcarbonyloxy, C5-Cheterocyclylcarbonyloxy, C-Cheteroalkoxy, wherein heteroalkyl, heteroalkoxy groups or heterocyclyl comprise 1, 2 or 3 heteroatoms selected from nitrogen, oxygen and sulphur, in which substituents the alkyl moieties are unsubstituted or further substituted; R3, R4 and R5 independently of one another, represent hydrogen or C-Calkyl; X1 and X2 independently of one another, represent a nitrogen atom or CR2, with the proviso that at least one of Xl and X2 represents a nitrogen atom; m is 1; and the (CH2)m moiety is optionally substituted by C-Calkyl; halogen, carboxy, hydroxy, C-Calkoxy, C-C-alkylcarbonyloxy, amino, mono- or di-(C-Calkyl)amino or acylamino n is 0, 1 or 2 or pharmaceutically acceptable salt thereof are valuable for use as a medicament for the treatment of bacterial infections.
Patent AU-2011205214-A1 (AU)
Title: Controlling the pressure within an annular volume of a wellbore
Inventor: LLEWELLYN BIRAN C
IPC: E21B33/13
Filed: 2011-08-08
Abstract: A process for controlling the pressure within a confined volume comprising: a) providing a volume containing a first fluid having a first pressure and a first temperature within the volume; 5 b) replacing at least a portion of the first fluid within the volume with a second fluid comprising at least one anhydrous inorganic material; c) sealing the volume to produce a confined volume; d) heating the fluid within the confined volume, such that the fluid is at a second pressure and at a second temperature; 10 wherein the second fluid is preselected such that the second pressure is lower than had the confined volume contained the first fluid only at the second temperature.
Patent AU-2011210043-A1 (AU)
Title: Liquid-crystal emulsion oil in water type and a preparation method of the liquid-crystal emulsion
Inventor: STEPIEN JACEK BERNARD
IPC: B01F23/47
Filed: 2011-01-28
Abstract: The present invention relates to liquid-crystal emulsion for the use in a termo- optical matrix to an early diagnosis of mammary gland neoplasmic lesions. It contains a mixture of thermotropic liquid crystals and polyvinyl alcohol. The liquid-crystal emulsion contains 14 to 48% by weight (on a dry matter basis) of the thermotropic compounds mixture and 50 to 86% by weight (on a dry matter basis) of polyvinyl alcohol. The present invention also relates to a method for preparing liquid-crystal emulsion.
Patent AU-2011213896-A1 (AU)
Title: Stable aqueous composite compositions
Inventor: BOHLING JAMES CHARLES
IPC: C08L31/00
Filed: 2011-08-25
Abstract: This invention provides a method for forming a stable aqueous composition including composite particles by admixing TiO2 particles and 5 adsorbing emulsion polymer particles at or below the critical composite ratio to an equilibrated viscosity range of from 200 cps to 4000 cps. Also provided is a method for forming a stable aqueous composition including composite particles by admixing TiO2 particles and adsorbing emulsion polymer particles at a mixing intensity of greater than 2 hp/kgal. A 10 method for providing a coating including composite particles is also included.
Patent AU-2011217004-A1 (AU)
Title: Titanium dioxide
Inventor: EDWARDS JOHN L
IPC: C09D7/48
Filed: 2011-02-11
Abstract: The invention provides a composition imparting UV protective capability comprising an effect coated particulate material having a substantially rutile crystal habit and an average particle size greater than or equal to about 0.5 µm dispersed in a medium at a concentration within a range of about 1% by volume to about 40% by volume, based on the total volume of composition. The composition may be coloured or non-coloured and applied onto one or more surfaces of a substrate to provide UV light protection without also increasing UV light activated photocatalytic effects which are generally observed.
Patent AU-2011218900-A1 (AU)
Title: Devices for treating morbid obesity using hydrogel
Inventor: BURRELL JANNA M
IPC: A61F5/00
Filed: 2011-02-09
Abstract: An environmentally sensitive hydrogel material swells or collapses in response to a parameter such as pH level associated with consumption of food by a patient. This swelling or collapsing is harnessed to treat morbid obesity or some other condition of the patient. The swelling or collapsing of the hydrogel may be used to tighten a gastric band or gastric valve when the patient starts eating; then loosen the band or valve when the patient is between meals. The swelling or collapsing of the hydrogel may also be used to increase the size of a space occupying device in the patient's stomach when the patient starts eating; then decrease the size of the space occupying device when the patient is between meals. The swelling or collapsing of the hydrogel may also be used to selectively restrict the absorption of nutrients within a patient's gastrointestinal tract, such as in the duodenum.
Patent AU-2011224364-A1 (AU)
Title: Electro-osmotic pumps, systems, methods, and compositions
Inventor: SHIN WOONSUP
IPC: F04B19/00
Filed: 2011-03-09
Abstract: The present disclosure relates, according to some embodiments, to compositions, methods, devices, and systems for delivering a composition (e.g., a fluid composition) to a subject. For example, the present disclosure relates to non-gassing, direct current (DC), electro-osmotic pumps in some embodiments. A pump may comprise an anode (e.g., a porous silver/silver oxide anode), a cathode (e.g., a porous silver/silver oxide cathode), and a membrane (e.g., a porous ceramic membrane) positioned at least partially between the anode and the cathode in some embodiments. A pump system may comprise an electro-osmotic pump, a reservoir comprising a pump fluid chamber in fluid communication with the electro- osmotic pump and a delivery fluid chamber in fluid communication with the electro-osmotic pump; a controller assembly in electrical communication with the anode and the cathode; and a cannula and/or a needle in fluid communication with the delivery fluid chamber. A pump fluid may comprise water and/or a delivery fluid may comprise a drug, in some embodiments.
Patent AU-2011250765-A1 (AU)
Title: Double strand compositions comprising differentially modified strands for use in gene modulation
Inventor: BALKRISHEN BHAT
IPC: C12N15/11
Filed: 2011-11-14
Abstract: The present invention provides douse stranded compositions wherein each strand is modified to have a motif defined by positioning of p-D- ribonucleosides and sugar modified nucleosides. More particularly, the present compositions comprise one strand having a gapped motif and another strand having a gapped motif, a hemimer motif, a blockmer motif, a fully modified motif, a positionally modified motif or an alternating motif. At least one of the strands has complementarity to a nucleic acid target. The compositions are useful for targeting selected nucleic acid molecules and modulating the expression of one or more genes. In some embodiments, the compositions of the present invention hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA. The present invention also provides methods for modulating gene expression.
Patent AU-2011253889-A1 (AU)
Title: A balance valve of asymmetric structure
Inventor: TUNG PING-JUNG
IPC: F16K31/64
Filed: 2011-12-08
Abstract: The present invention provides a balance valve of asymmetric structure, which is accommodated in the holding space preset into the dual-temperature ceramic valve; the first and second lateral end walls are separately set at both ends of the holding space; the balance valve comprises: fixed valve pipe and moveable spool, of which the moveable spool is transversely assembled into the fixed valve pipe in a transverse movement state; the first end of the moveable spool is recessed to form a hot water slot, and the second end recessed to form a cold water slot; the hot/cold water slots are separated by a partition; moreover, the hot water slot is provided with a hot water punch hole connected with the hot water opening of the fixed valve pipe, the cold water slot is provided with a cold water punch hole connected with the cold water opening of the fixed valve pipe; the present invention is characterized by that, the balance valve comprises an asymmetric structure, which is extended asymmetrically by the first ends and second ends of the fixed valve pipe or the moveable spool; or expanded asymmetrically by the hot/cold water openings of the fixed valve pipe, or expanded asymmetrically by the hot/cold water punch holes of the moveable spool; with this design, if the dual-temperature ceramic valve is switched to cold/hot water supply modes and the hot-water line is blocked to make the moveable spool abutted towards the first lateral end wall of the holding space, a cold water channel is formed between the cold water opening of the fixed valve pipe and the second end of the moveable spool to maintain cold water supply function, thus realizing improved ease of operation and applicability. 101 56 523 524
Patent AU-2011278492-A1 (AU)
Title: Foam enhancement of fatty acyl glycinate surfactants
Inventor: DASGUPTA BIVASH RANJAN
IPC: A61K8/41
Filed: 2011-07-04
Abstract: A personal care cleansing composition is provided which includes a C
Patent AU-2011285672-A1 (AU)
Title: Dual mode agent discharge system with multiple agent discharge capability
Inventor: REILLY WILLIAM J
IPC: A62C31/02
Filed: 2011-08-04
Abstract: An emitter system capable of discharging an atomized liquid-gas stream or a liquid stream which atomizes into a spray has a source of pressurized gas and one or more sources of pressurized liquids. Flow of gas and liquid to an emitter is controlled by valves, and the emitter can be used to discharge either the atomized liquid-gas stream or the liquid stream. The emitter system may be used for fire suppression.
Patent AU-2011285688-A1 (AU)
Title: Process and system for separating heavy and light components contained in a vapor mixture
Inventor: LUCE GARY W
IPC: B01D53/14
Filed: 2011-08-04
Abstract: Herein disclosed is a method of separating heavy and light components from a vapor mixture. The method comprises a. distilling the vapor mixture into a first vapor phase and a first liquid phase; and b. condensing at least a portion of the first vapor phase into a second liquid phase and a second vapor phase; wherein the distilling utilizes the internal energy of the vapor mixture. In an embodiment, the method further comprises c. utilizing at least a portion of the first liquid phase to absorb at least a portion of the second vapor phase. In some cases, the method further comprises cooling the at least a portion of the first liquid phase prior to utilizing it to absorb the at least a portion of the second vapor phase.
Patent AU-2011331905-A1 (AU)
Title: Signal transduction pathway modulation
Inventor: MATTES JOERG
IPC: A61P37/08
Filed: 2011-11-15
Abstract: Provided herein are methods and compositions for modulating signal transduction pathways by regulating the expression and/or activity of Midline-1, enabling the inhibition of airways inflammation, the inhibition of airways hyperresponsiveness, the inhibition of rhinovirus-associated inflammation, and reductions in cytokine and chemokine release. Methods and compositions disclosed herein facilitate the treatment and prevention of conditions associated with airway inflammation, airway tissue remodelling and rhinovirus-associated inflammation and symptoms, manifestations and exacerbations thereof, in particular of allergic diseases such as allergic airways diseases including asthma.
Patent AU-2011331939-A1 (AU)
Title: Modular antenna for implantable medical device
Inventor: VAJHA SASIDHAR
IPC: A61N1/372
Filed: 2011-11-22
Abstract: Subject matter such as a method or apparatus can include an implantable antenna assembly, comprising a dielectric shell including first and second substantially parallel outer face portions, and a third outer face portion extending between the first and second portions, a spiral conductor extending along the first, second, and third portions on a surface of the dielectric shell. The dielectric shell and spiral conductor can be configured to be mechanically attached to a dielectric compartment, such as configured to be coupled to a housing of an implantable medical device. In an example, the implantable antenna assembly is configured to be electrically coupled to an implantable telemetry circuit configured to wirelessly transfer information electromagnetically using the implantable telemetry antenna, such as included as a portion of an implantable medical device.
Patent AU-2011341697-A1 (AU)
Title: Oral care dispenser
Inventor: JIMENEZ EDUARDO J
IPC: A46B11/00
Filed: 2011-07-22
Abstract: An oral care dispenser and oral care system incorporating the system that includes a resilient applicator that optimizes application of the subject fluid to the desired oral surfaces. In one embodiment, the invention is a dispenser comprising a housing having an internal reservoir containing the fluid. The resilient applicator is coupled to the housing and comprises a dispensing orifice. The resilient applicator comprises a working surface that is oriented at an oblique angle to a longitudinal axis of the housing and is defined by a polygonal perimeter edge, the polygonal perimeter edge comprising a plurality of apex portions and a plurality of side portions, wherein one of the plurality of side portions forms a distal most-portion of the resilient applicator.
Patent AU-2011348479-A1 (AU)
Title: Optically variable element, in particular a security element for a data storage medium
Inventor: FRANZ PETER
IPC: B42D15/00
Filed: 2011-12-16
Abstract: The invention relates to an optically variable element, in particular a security element for a data storage medium, having a substrate (6) comprising a reflective layer (7), which is provided with a pattern-forming surface structure having a first and a second sub-region (4, 5), wherein the two sub-regions (4, 5) can each be optically perceived as protruding and/or receding, respectively, the optically perceptible and the haptically detectable impressions of the first sub-region (4) agree with each other, and the optically perceptible and the haptically detectable impressions of the second sub-region (5) do not agree with each other.